Quantcast
Last updated on April 17, 2014 at 14:35 EDT

Latest BRAVELLE Stories

2014-03-19 08:30:18

PARSIPPANY, N.J., March 19, 2014 /PRNewswire-USNewswire/ -- Ferring Pharmaceuticals Inc. today announced FDA approval of new labeling for their fertility products, MENOPUR and BRAVELLE. The label update is a result of the COMBINE trial which demonstrated that both MENOPUR and BRAVELLE can be safely mixed and administered in a single injection. Approval was granted on February 19, 2014 and designates Ferring's mixed protocol as the only combination of IVF stimulation gonadotropins to...

2012-04-23 02:28:55

PARSIPPANY, N.J., April 23, 2012 /PRNewswire/ -- Celebrating National Infertility Awareness Week, April 22-28, 2012, Ferring Pharmaceuticals is honoring three lucky families who won its national 2011 My Little Miracle Essay Contest for their heart-warming and inspirational stories about their journey to parenthood. The contest celebrates the birth of children who were conceived using Ferring's MENOPUR® (menotropins for injection, USP) and/or BRAVELLE® (urofollitropin for injection,...

2008-09-29 12:00:14

PARSIPPANY, N.J., Sept. 29 /PRNewswire/ -- Ferring Pharmaceuticals today announced a new, expanded cost-saving program for patients who are considering fertility treatment, but find the costs a challenge. Ferring's HEART (Helping Expand Access to Reproductive Therapy) Rx Initiative gives women greater access to fertility medications by providing significant cost savings on two frequently prescribed fertility treatments. The program now includes both BRAVELLE(R) (urofollitropin for...

2008-01-02 12:00:10

PARSIPPANY, N.J., Jan. 2 /PRNewswire/ -- Ferring Pharmaceuticals today announced a new, improved cost-saving program for patients who are considering fertility treatment, but find the costs a challenge. Ferring's HEART (Helping Expand Access to Reproductive Therapy) Program gives women greater access to fertility medications, saving them as much as $700 on two frequently prescribed fertility treatments. The expanded program now includes both BRAVELLE(R) (urofollitropin for injection,...